Andrew Craig Miller - 10 May 2021 Form 4 Insider Report for Karuna Therapeutics, Inc.

Role: Chief Operating Officer
Signature: /s/ Troy Ignelzi, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 10 May 2021
Net transactions value: -$506,150
Form type: 4
Filing time: 12 May 2021, 17:29:58 UTC
Next filing: 14 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KRTX	Common Stock	Options Exercise	$46,000	+5,000	+11%	$9.20^*	50,500	10 May 2021	Direct
transaction	KRTX	Common Stock	Sale	$552,150	-5,000	-9.9%	$110.43	45,500	10 May 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KRTX	Option (right to buy)	Options Exercise	$0	-5,000	-1.6%	$0.000000	300,492	10 May 2021	Common Stock	5,000	$9.20	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.